Engineering patient-derived tumoroids to enable high-throughput screening for immuno-oncology...
Вставка
- Опубліковано 8 сер 2024
- Presented By: Garrett Wong, MS
Speaker Biography: Garrett Wong received his MS in 2017 from University of California, San Diego modeling the role of skeletal muscle in spinal bulbar muscular atrophy using iPSCs. Starting off as a junior scientist in 2018, now, he is a manager for the cell biology services team at Thermo Fisher Scientific...
Webinar: Engineering patient-derived tumoroids to enable high-throughput screening for immuno-oncology...
Webinar Abstract: Patient-derived tumoroids, commonly referred to as cancer organoids, represent a promising avenue as cost-effective and biologically relevant cancer immunotherapy research models. In this study, we developed a proof-of-concept immunotherapy screening platform harnessing tumoroids to validate the cytotoxic activity of Natural Killer (NK) cells...
Labroots on Social:
Facebook: / labrootsinc
Twitter: / labroots
LinkedIn: / labroots
Instagram: / labrootsinc
Pinterest: / labroots
SnapChat: labroots_inc - Наука та технологія